Femto Technologies to Present AI-Powered Femtech Innovations at Aegis Capital Financial Conference

Femto Technologies Inc., a Nasdaq-listed company recognized for its innovative artificial intelligence applications in feminine wellness, is scheduled to present at the Aegis Capital Financial Conference from May 20-22, 2025. The conference serves as a critical platform connecting industry experts, investors, and stakeholders interested in emerging technologies with transformative potential. Femto will demonstrate its latest advancements in harnessing artificial intelligence within the feminine wellness sector alongside biofeedback sensor-driven analytics.

The Aegis Capital Financial Conference, facilitated both virtually and in person in New York City, is hosted by Aegis Capital Corp., a premier full-service investment entity operating since 1984. The firm provides corporate finance, strategic advisory, research, sales, and trading services to institutional and retail investors. Femto's participation in this prestigious event underscores the growing importance of femtech innovations in the investment landscape and the increasing recognition of women's health technology as a significant market opportunity.

Femto's presentation will focus on how its proprietary Smart Release System technology, embedded in the Sensera platform, is shaping the future of AI-powered femtech intelligence. The technology, which recently received recognition as a CES Innovation Awards 2025 honoree in the AI category, represents a pioneering approach to enhancing real-time analytics and improving women's lives globally. The company's CEO, Yftah Ben Yaackov, emphasized the significance of this opportunity to engage with leading investors and decision-makers, stating that it allows Femto to demonstrate how their technology drives real-world impact in AI-enhanced solutions.

The implications of Femto's conference presentation extend beyond mere corporate visibility. It signals the maturation of the femtech industry and the increasing integration of artificial intelligence and sensor technology in women's health solutions. For more information about the company's developments, investors and interested parties can visit https://www.femtocorp.com. The company's regulatory filings and additional financial information are available through https://www.sedarplus.ca, providing transparency regarding its operations and future prospects.

While the devices described remain in the early development stage and subject to testing and regulatory approvals, Femto's presence at this high-profile financial conference demonstrates the growing investor confidence in AI-driven femtech solutions. The event provides a platform for the company to articulate its vision for transforming feminine wellness through technology while attracting potential investment that could accelerate research, development, and eventual market deployment of its innovative products.